Results for tag: "N Formyl Peptide Receptor 2"

The N Formyl Peptide Receptor 2 (FPR2) market is a subset of the Immune Disorders Drugs market. FPR2 is a G-protein coupled receptor that is involved in the regulation of inflammation and immune responses. It is a target for the development of novel drugs for the treatment of inflammatory and immune-related diseases. FPR2 agonists have been shown to reduce inflammation and improve symptoms in animal models of inflammatory diseases. FPR2 agonists are being developed for the treatment of a variety of inflammatory and immune-related diseases, including asthma, rheumatoid arthritis, inflammatory bowel disease, and psoriasis. Several companies are actively developing FPR2 agonists, including AbbVie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more